<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02164058</url>
  </required_header>
  <id_info>
    <org_study_id>CA 2011-01</org_study_id>
    <nct_id>NCT02164058</nct_id>
  </id_info>
  <brief_title>TandemHeart to Reduce Infarct Size (TRIS Trial)</brief_title>
  <acronym>TRIS</acronym>
  <official_title>A Randomized Controlled Multicenter Study on the Use of the TandemHeart to Reduce Infarct Size</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CardiacAssist, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CardiacAssist, Inc.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if a device known as the TandemHeart® System
      (TandemHeart) can help limit heart damage and reduce serious complications after a certain
      type of heart attack (acute ST elevation anterior wall myocardial infarction [STEMI]) by
      evaluating the use of the TandemHeart system prior to a procedure called percutaneous
      coronary intervention (PCI)
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    No participants enrolled
  </why_stopped>
  <start_date>January 2015</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">August 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Safety</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>Major Adverse Cardiac or Cerebrovascular Events (MACCE):
Death, all cause
Stroke
Reinfarction
Major vascular complications</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>TandemHeart System + PCI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TandemHeart System prior to percutaneous coronary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous coronary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TandemHeart System</intervention_name>
    <arm_group_label>TandemHeart System + PCI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous coronary intervention</intervention_name>
    <arm_group_label>TandemHeart System + PCI</arm_group_label>
    <arm_group_label>PCI</arm_group_label>
    <other_name>PCI</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        INCLUSION CRITERIA

        The following is a list of general inclusion criteria. More detailed information can be
        found in the study protocol.

          1. ≥ 18 years of age

          2. Presents within 6 hours of acute MI symptoms

          3. Evidence of ST elevation

          4. First myocardial infarction

          5. Written informed consent

        EXCLUSION CRITERIA

        The following is a list of general exclusion criteria. More detailed information can be
        found in the study protocol.

          1. Contraindications to antiplatelet/anticoagulation therapy

          2. History of blood disorders or active bleeding

          3. Renal dysfunction or failure

          4. Neurologic damage

          5. Cardiogenic shock

          6. History of cerebrovascular disease

          7. History of transfusion reaction

          8. Prior coronary artery bypass surgery

          9. Participation in another trial with an investigational drug or device

         10. Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2014</study_first_submitted>
  <study_first_submitted_qc>June 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2014</study_first_posted>
  <last_update_submitted>December 3, 2015</last_update_submitted>
  <last_update_submitted_qc>December 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 4, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>STEMI</keyword>
  <keyword>ST elevation MI</keyword>
  <keyword>Acute MI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

